---
pmid: '24229708'
title: Runx3 inactivation is a crucial early event in the development of lung adenocarcinoma.
authors:
- Lee YS
- Lee JW
- Jang JW
- Chi XZ
- Kim JH
- Li YH
- Kim MK
- Kim DM
- Choi BS
- Kim EG
- Chung JH
- Lee OJ
- Lee YM
- Suh JW
- Chuang LS
- Ito Y
- Bae SC
journal: Cancer Cell
year: '2013'
full_text_available: false
doi: 10.1016/j.ccr.2013.10.003
---

# Runx3 inactivation is a crucial early event in the development of lung adenocarcinoma.
**Authors:** Lee YS, Lee JW, Jang JW, Chi XZ, Kim JH, Li YH, Kim MK, Kim DM, Choi BS, Kim EG, Chung JH, Lee OJ, Lee YM, Suh JW, Chuang LS, Ito Y, Bae SC
**Journal:** Cancer Cell (2013)
**DOI:** [10.1016/j.ccr.2013.10.003](https://doi.org/10.1016/j.ccr.2013.10.003)

## Abstract

1. Cancer Cell. 2013 Nov 11;24(5):603-16. doi: 10.1016/j.ccr.2013.10.003.

Runx3 inactivation is a crucial early event in the development of lung 
adenocarcinoma.

Lee YS(1), Lee JW, Jang JW, Chi XZ, Kim JH, Li YH, Kim MK, Kim DM, Choi BS, Kim 
EG, Chung JH, Lee OJ, Lee YM, Suh JW, Chuang LS, Ito Y, Bae SC.

Author information:
(1)Department of Biochemistry, College of Medicine, Chungbuk National 
University, Cheongju 361-763, South Korea.

Targeted inactivation of Runx3 in mouse lung induced mucinous and nonmucinous 
adenomas and markedly shortened latency of adenocarcinoma formation induced by 
oncogenic K-Ras. RUNX3 was frequently inactivated in K-RAS mutated human lung 
adenocarcinomas. A functional genetic screen of a fly mutant library and 
molecular analysis in cultured cell lines revealed that Runx3 forms a complex 
with BRD2 in a K-Ras-dependent manner in the early phase of the cell cycle; this 
complex induces expression of p14(ARF)/p19(Arf) and p21(WAF/CIP). When K-Ras was 
constitutively activated, the Runx3-BRD2 complex was stably maintained and 
expression of both p14(ARF) and p21(WAF/CIP) was prolonged. These results 
provide a missing link between oncogenic K-Ras and the p14(ARF)-p53 pathway, and 
may explain how cells defend against oncogenic K-Ras.

Copyright Â© 2013 Elsevier Inc. All rights reserved.

DOI: 10.1016/j.ccr.2013.10.003
PMID: 24229708 [Indexed for MEDLINE]
